Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 12.32
-0.11 (-0.88%)
Jul 21, 2026, 3:04 PM CST
SHE:300601 Market Cap
SHE:300601 has a market cap or net worth of 13.76 billion as of July 21, 2026. Its market cap has decreased by -24.60% in one year.
Market Cap
13.76B
Enterprise Value
13.81B
Revenue
2.66B
Ranking
n/a
PE Ratio
177.38
Stock Price
12.32
ChartMarket Cap Chart
Since February 7, 2017, SHE:300601's market cap has increased from 1.95B to 13.76B, an increase of 606.34%. That is a compound annual growth rate of 22.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 13.76B | -16.59% |
| Dec 31, 2025 | 16.50B | -13.88% |
| Dec 31, 2024 | 19.16B | -36.83% |
| Dec 29, 2023 | 30.32B | 11.35% |
| Dec 30, 2022 | 27.23B | -59.77% |
| Dec 31, 2021 | 67.70B | -43.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haoyuan Chemexpress | 15.08B |
| Fujian Cosunter Pharmaceutical | 14.65B |
| Harbin Pharmaceutical Group | 13.42B |
| Zhejiang Jiuzhou Pharmaceutical | 13.30B |
| Zhejiang Hisun Pharmaceutical | 13.11B |
| Shenzhen Hepalink Pharmaceutical Group | 13.00B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.75B |
| Shenzhen Chipscreen Biosciences | 12.75B |